# Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

> **NCT00895232** · PHASE2 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Cohort I
- **DRUG:** Cohort II
- **DRUG:** Cohort III

## Key facts

- **NCT ID:** NCT00895232
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-08
- **Final completion:** 2005-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895232, "Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00895232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*